Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Studies demonstrate that methamphetamine (meth) use is associated with high-risk sexual
behavior among men who have sex with men (MSM), putting meth-using MSM at extraordinarily
high risk for transmitting or acquiring HIV. This study is a randomized, double-blind,
placebo-controlled trial of the medication aripiprazole for methamphetamine-using
individuals, including MSM, and will assess efficacy, acceptability, tolerability, safety,
and adherence to study medication.